Jabir Majid S, Saleh Yasmin M, Sulaiman Ghassan M, Yaseen Nahi Y, Sahib Usama I, Dewir Yaser Hassan, Alwahibi Mona S, Soliman Dina A
Department of Applied Sciences, University of Technology, Baghdad 10066, Iraq.
College of Education, Mustansiriyah University, Baghdad 10052, Iraq.
Nanomaterials (Basel). 2021 Feb 3;11(2):384. doi: 10.3390/nano11020384.
is one of the most important traditional medicinal plants which contains numerous chemicals that exhibit various pharmacological properties. In this study, silver nanoparticles were prepared using peel extract as a reducing agent and the effect was enhanced through like pharmaceutical activity. AgNPs formation was confirmed by color changes, UV-visible spectroscopy, SEM, DLS, and XRD. The anti-proliferative activity of AgNPs against THP-1, AMJ-13, and HBL cell lines was studied. Apoptotic markers were tested using AO/EtBr staining assay, cell cycle phases using flowcytometry, and the expression of P53. Autophagy takes an essential part in controlling inflammasome activation by primary bone marrow-derived macrophages (BMDMs). We report novel functions for AgNPs-affected autophagy, represented by the control of the release of IL-1β, caspase-1, adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC), and NLRP3 in BMDMs following treatment with LPS+ATP. The current study revealed that the AgNPs inhibited THP-1 and AMJ-13 cell proliferation. Meanwhile, the AgNPs significantly increased autophagy and reduced IL-1b and NLRP3 levels in both in vivo and in vitro models. The secretion of IL-1β was reduced whereas the degradation of NLRP3 inflammasome was enhanced. These findings propose that AgNPs apply an anti-proliferative activity against THP-1 and AMJ-13 cells through the stimulation of apoptosis via mitochondrial damage and induction of p53 protein pathway. In addition, AgNP-induced autophagy reduced the levels of IL-1β and NLRP3 inflammasome activation. This indicated that the AgNPs augment autophagy controlled by the IL-1β pathway via two different novel mechanisms. The first one is regulating activation of the IL-1 β, caspae-1, and ASC, while the second is NLRP3 targeting for lysosomal degradation. Overall, this study suggests that AgNPs could be a potent therapy for various types of cancer and an alternative treatment for preventing inflammation via enhancing autophagy.
是最重要的传统药用植物之一,含有多种具有不同药理特性的化学物质。在本研究中,以果皮提取物为还原剂制备了银纳米颗粒,并通过类似药物活性增强了其效果。通过颜色变化、紫外可见光谱、扫描电子显微镜、动态光散射和X射线衍射确认了银纳米颗粒的形成。研究了银纳米颗粒对THP-1、AMJ-13和HBL细胞系的抗增殖活性。使用AO/EtBr染色法检测凋亡标记物,使用流式细胞术检测细胞周期阶段,并检测P53的表达。自噬在控制原代骨髓来源巨噬细胞(BMDM)的炎性小体激活中起重要作用。我们报告了银纳米颗粒影响自噬的新功能,表现为在用LPS+ATP处理后,BMDM中IL-1β、半胱天冬酶-1、含有CARD的凋亡相关斑点样蛋白适配器(ASC)和NLRP3的释放受到控制。当前研究表明,银纳米颗粒抑制THP-1和AMJ-13细胞增殖。同时,在体内和体外模型中,银纳米颗粒均显著增加自噬并降低IL-1b和NLRP3水平。IL-1β的分泌减少,而NLRP3炎性小体的降解增强。这些发现表明,银纳米颗粒通过线粒体损伤诱导凋亡和诱导p53蛋白途径,对THP-1和AMJ-13细胞具有抗增殖活性。此外,银纳米颗粒诱导的自噬降低了IL-1β水平和NLRP3炎性小体激活。这表明银纳米颗粒通过两种不同的新机制增强了由IL-1β途径控制的自噬。第一种机制是调节IL-1β、半胱天冬酶-1和ASC的激活,第二种机制是靶向NLRP3进行溶酶体降解。总体而言,本研究表明,银纳米颗粒可能是治疗多种癌症的有效疗法,也是通过增强自噬预防炎症的替代治疗方法。